OP-6A - Utilization of Non-pharmacologic Pain Therapies Among Primary Care Physicians in the United States: A Cross-sectional Survey
Location: OP-06
Drug Utilization Research
Monday, Aug 23rd
11:45 AM - 1:30 PM US Eastern Time
OP-6B - Prevalence of Osteoporosis and Its Treatment Among Women ≥50 in NHANES: 1999-2018
Location: OP-06
Drug Utilization Research
Monday, Aug 23rd
11:45 AM - 1:30 PM US Eastern Time
OP-6C - Serum Vitamin D Levels and Incident Prescription Opioid Use Among Opioid-naïve Patients
Location: OP-06
Drug Utilization Research
Monday, Aug 23rd
11:45 AM - 1:30 PM US Eastern Time
OP-6E - Primary Care Physicians’ Preparedness to Treat Opioid Use Disorder in the United States: A Cross-sectional Survey
Location: OP-06
Drug Utilization Research
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-14A - Trends in Long-term Use of Prescribed Opioids in Norway 2010-2019
Location: OP-14
Drug Utilization Research
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-14C - Trends and Outcomes of Serious Complications Associated with Non-fatal Opioid Overdoses in Ontario, Canada
Location: OP-14
Drug Utilization Research
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-14D - Geographic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Population in the United States
Location: OP-14
Drug Utilization Research
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-14E - Trajectories of Pregabalin Use and Their Association with Longitudinal Changes in Opioid and Benzodiazepine Daily Dose
Location: OP-14
Drug Utilization Research
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-14F - Prior Opioid Tolerance Among New Users of Transdermal Fentanyl in Taiwan, 2011-2018
Location: OP-14
Drug Utilization Research
Monday, Aug 23rd
3:30 PM - 5:00 PM US Eastern Time
WS-05 - Drug Utilization Research in Africa: Challenges and Potential Solutions
Location: WS-05
Drug Utilization Research
Monday, Aug 23rd
5:30 PM - 6:30 PM US Eastern Time
L-1J - Patterns of Antibiotic Prescription Among Adult Outpatients in Italy
Location: L-1
Drug Utilization Research
Monday, Aug 23rd
5:30 PM - 6:30 PM US Eastern Time
L-1K - Determinants of Antimalarial Prescription Patterns Among Health Care Providers in Public Health Facilities in Uasin Gishu County, Kenya
Location: L-1
Drug Utilization Research
Monday, Aug 23rd
5:30 PM - 6:30 PM US Eastern Time
L-1L - Co-utilization of Opioids and Non-benzodiazepine Sedative Hypnotics in U.S. Ambulatory Care Visits, 2006 – 2016
Location: L-1
Drug Utilization Research
Monday, Aug 23rd
5:30 PM - 6:30 PM US Eastern Time
L-1M - Early Uptake of New Molecular Entities Approved in 2017 in a Multisite National US Healthcare Data Network
Location: L-1
Drug Utilization Research
Monday, Aug 23rd
6:30 PM - 7:30 PM US Eastern Time
L-2A - Changes in Purchases of Intensive Care Medicines During COVID-19 in Developed vs. Developing Countries
Location: L-2
Drug Utilization Research
Tuesday, Aug 24th
1:45 PM - 3:30 PM US Eastern Time
OP-23A - Heterogeneity and Temporal Variation in the Management of COVID-19: A Multinational Drug Utilisation Study Including 274,719 Hospitalised Patients From, the United States of America, China, Spain, and South Korea
Location: OP-23
Drug Utilization Research
Tuesday, Aug 24th
1:45 PM - 3:30 PM US Eastern Time
OP-23B - Real World Use of Anticoagulation Among Hospitalized Patients with COVID-19 in the United States
Location: OP-23
Drug Utilization Research
Tuesday, Aug 24th
1:45 PM - 3:30 PM US Eastern Time
OP-23E - Use of Cardiovascular and Antidiabetic Drugs During COVID19 Epidemic in France
Location: OP-23
Drug Utilization Research
Tuesday, Aug 24th
1:45 PM - 3:30 PM US Eastern Time
OP-23F - Substantial Heterogeneity in the Management of Hospitalized Patient with COVID-19
Location: OP-23
Drug Utilization Research
Tuesday, Aug 24th
1:45 PM - 3:30 PM US Eastern Time
OP-25F - Non-adherence and Non-persistence with Direct Oral Anticoagulants Increases the Risk of Stroke: Assessment in Three European Databases
Location: OP-25
Drug Utilization Research
Tuesday, Aug 24th
1:45 PM - 3:30 PM US Eastern Time
OP-28E - Visualizing Inappropriate Antibiotic Use Following Otitis Media in Children in the United States
Location: OP-28
Drug Utilization Research
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP01A - Incidence and Predictors of Primary Nonadherence to Sodium Glucose Co-transporter 2 Inhibitors and Glucagon Like Peptide 1 Agonists in a Large Integrated Healthcare System
Location: SP01
Drug Utilization Research
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP01B - Comparing FOLFOX Delivery in Trial and Real-world Populations Using Longitudinal Cumulative Dose
Location: SP01
Drug Utilization Research
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP01C - Low Persistence of Antipsychotic Therapy in Parkinson Disease – Intolerance, Ineffectiveness, or Inertia?
Location: SP01
Drug Utilization Research
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP01E - Factors Associated with Adherence to Newly Initiated JAK Inhibitors in Rheumatoid Arthritis Patients
Location: SP01
Drug Utilization Research
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP01G - Comparison of Measures for Medication Adherence of Antihypertensive Drugs Using National Health Insurance Claims Data
Location: SP01
Drug Utilization Research
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP01H - Adherence and Associated Factors of Treatment Regimen in Drug-susceptible tuberculosis Patients
Location: SP01
Drug Utilization Research
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP02A - Tramadol Dominating the Longitudinal Trajectories of Chronic Opioid Prescribing and Co-medication in Non-cancer Patients in Taiwan
Location: SP02
Drug Utilization Research
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP02G - Adherence to Medication: Patient Reported Facilitators and Barriers
Location: SP02
Drug Utilization Research
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP03F - Utilisation and Treatment Patterns of Medicines to Manage Relapsing Remitting Multiple Sclerosis: Implications for Pharmacovigilance
Location: SP03
Drug Utilization Research
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP09D - Drug Utilization Research in Africa: Key Research Challenges
Location: SP09
Drug Utilization Research
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP09E - The Impact of Regulatory Restrictions on the Use of Pregabalin: An Interrupted Time-series
Location: SP09
Drug Utilization Research
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP10A - Drug Utilization and Prescribing Pattern of Concomitant Use of Enzalutamide and Anticoagulation
Location: SP10
Drug Utilization Research
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP15H - Children’s Relative Age and Medicine Treatment for Attention-deficit/hyperactivity Disorder (ADHD) Across Australian Jurisdictions with Different School Enrolment Policies
Location: SP15
Drug Utilization Research
Tuesday, Aug 24th
6:45 PM - 7:45 PM US Eastern Time
L-3H - Analytical Enhancements in Kentucky’s Drug Overdose Mortality Surveillance: Rapid Monitoring of Trends and Decedents’ Recent Controlled Substance Prescription History
Location: L-3
Drug Utilization Research
Tuesday, Aug 24th
6:45 PM - 7:45 PM US Eastern Time
L-3J - Measuring Mental Health Prescribing Safety Indicators in UK Primary Care
Location: L-3
Drug Utilization Research
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-5E - Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized with COVID-19 in the United states:
results from the National COVID Cohort Collaborative (N3C)
Location: OP-05
Drug Utilization Research
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-5F - COVID-19 in Children: Treatment Patterns in the Real-world Hospital Setting
Location: OP-05
Drug Utilization Research
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-10A - Disparities in Hepatitis C Treatment in the Era of Direct-acting Antivirals Among Arizona Medicaid Beneficiaries
Location: OP-10
Drug Utilization Research
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-10B - Sources of Racial/ethnic Disparities in Antidepressant Treatment: Analysis of the Medical Expenditure Panel Survey Data
Location: OP-10
Drug Utilization Research
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-10C - Do Medicare Part D Low-income Subsidies Narrow Disparities in Orally-administered Antimyeloma Therapy Initiation?
Location: OP-10
Drug Utilization Research
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-10E - The Impact of Sex on the Quality of Medication Treatment in Patients with Type 2 Diabetes
Location: OP-10
Drug Utilization Research
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-10F - Changes in Buprenorphine Utilization During the COVID-19 Pandemic in the US
Location: OP-10
Drug Utilization Research
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-12B - Ranitidine and Other histamine2-receptor Antagonists – a Rapid Response Drug Utilisation Study Using Electronic Health Care Data from Six European Countries
Location: OP-12
Drug Utilization Research
Wednesday, Aug 25th
3:00 PM - 4:30 PM US Eastern Time
OP-8B - Influence of Drug Safety Advisories on Drug Utilization: An International Interrupted Time Series and Meta-analysis Study
Location: OP-08
Drug Utilization Research
Wednesday, Aug 25th
3:00 PM - 4:30 PM US Eastern Time
PP-01D - Nondifferential Treatment Misclassification Biases Toward the Null? Not a Safe Bet
